Health Care

Agios Pharmaceuticals (NASDAQ:AGIO) Lifted to "Sell" at BidaskClub

It operates through three divisions: Hotel Operations, Real Estate Operations, and Investment Transactions. It now has negative earnings. The institutional investor held 7.08M shares of the homebuilding company at the end of 2017Q3, valued at $405.86M, down from 8.16 million at the end of the previous reported quarter. BlackRock Advisors LLC now owns 253,023 shares of the biopharmaceutical company's stock valued at $10,600,000 after buying an additional 240,636 shares in the last quarter. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.

Since August 1, 2017, it had 0 insider buys, and 14 selling transactions for $14.88 million activity. (NASDAQ:AGIO). Sg Americas Ltd Liability Com owns 7,625 shares or 0% of their U.S. portfolio.

A number of institutional investors and hedge funds have recently made changes to their positions in AGIO. (NASDAQ:CHRW) or 406,543 shares. Deutsche Bank & Trust Ag reported 1.09M shares. Investors who observing the volume trend of argenx SE (ARGX) over recent time; they noted that 0.17 million shares changed at hands contradiction to its average trading volume of 0.21 million. About 290,001 shares traded. Lennar Corporation (NYSE:LEN) has risen 19.91% since January 12, 2017 and is uptrending. It has underperformed by 4.57% the S&P500. S&CO Inc. purchased a new position in shares of Agios Pharmaceuticals during the third quarter worth approximately $227,000. (AGIO) delivered a -11.36% earnings surprise. The biopharmaceutical company reported ($1.59) earnings per share for the quarter, beating the consensus estimate of ($1.78) by $0.19. During the same quarter last year, the firm earned ($1.63) earnings per share. analysts predict that Agios Pharmaceuticals will post -6.59 earnings per share for the current fiscal year.

Investors sentiment decreased to 1.21 in Q3 2017. Its down 0.23, from 1.24 in 2017Q2. On Monday, October 16 Cantley Lewis Clayton Jr. sold $284,380 worth of Agios Pharmaceuticals, Inc. 37 funds opened positions while 150 raised stakes. Belpointe Asset Management LLC bought a new stake in Agios Pharmaceuticals during the third quarter worth about $1,250,000. Weiss Asset Mgmt L P holds 2,997 shares. Thomas White Interest Limited holds 11,650 shares. Bb Biotech Ag sold 119,530 shares as the company's stock declined 9.11% while stock markets rallied. Hightower Advisors Ltd Liability Corp invested in 78,951 shares or 0.04% of the stock. 30,734 are owned by Parallax Volatility Advisers Lp. C Grp Holdings A S owns 0% invested in Agios Pharmaceuticals, Inc. Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) has risen 8.52% since January 11, 2017 and is uptrending. Bowden Christopher also sold $390,000 worth of Agios Pharmaceuticals, Inc. Credit Suisse Group lifted their price objective on shares of Agios Pharmaceuticals from $61.00 to $66.00 and gave the stock an "outperform" rating in a research report on Thursday, November 2nd. The stock increased 9.02% or $6.0747 during the last trading session, reaching $73.4147. 505,000 shares of the company traded hands, compared to its average volume of 474,250. It has underperformed by 8.18% the S&P500.

Sell-side analyst recommendations point to a short term price target of $77.67 on the shares of Agios Pharmaceuticals, Inc. Therefore 75% are positive. The stock is trading for about -7.41% less than its 52-week high.

Here we'll take a quick glance at how the stock price is now trading in relation to some of its simple moving averages. Agios Pharmaceuticals had 41 analyst reports since July 23, 2015 according to SRatingsIntel. Oppenheimer maintained Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) for 3,800 shares. Oppenheimer has "Buy" rating and $7500 target. (NASDAQ:AGIO) has "Buy" rating given on Monday, June 13 by Canaccord Genuity. The firm has "Positive" rating given on Wednesday, March 30 by Susquehanna. As per Monday, October 16, the company rating was upgraded by Keefe Bruyette & Woods.

WARNING: "Agios Pharmaceuticals (AGIO) Upgraded at Zacks Investment Research" was posted by The Lincolnian Online and is owned by of The Lincolnian Online. (NASDAQ:AGIO). Virginia-based Quantitative Mngmt Ltd Liability Corp has invested 0.13% in Agios Pharmaceuticals, Inc. The firm is also developing Ivosidenib, a potent inhibitor of the mutated IDH1 protein, which is in Phase 1 clinical trial for patients with advanced hematologic malignancies with an IDH1 mutation; Phase 1 clinical trial for advanced solid tumors; Phase 3 clinical trial for patients with nonresectable or metastatic cholangiocarcinoma with an IDH1 mutation; Phase 1b frontline combination trial for patients with newly diagnosed AML with an IDH2 or IDH1 mutation; and Phase 1/2 frontline combination and Phase 3 clinical trials for newly diagnosed AML patients.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.



Like this

Latest


13 January 2018
American Airlines Group Inc. (AAL) Analysts See $0.71 EPS
Thrivent Financial For Lutherans increased its position in American Airlines Group by 0.6% in the second quarter. (NASDAQ:CBSH). Blue Edge Capital Llc increased Ishares Iboxx Investment Grade (LQD) stake by 96 shares to 20,592 valued at $2.50B in 2017Q3.

13 January 2018
Warner Bros. Sets Release Date For 'Shazam!'
Levi recently said the movie will be like a cross between Superman and and the Tom Hanks body-swap comedy Big . Sandberg adapts the comic about a young boy who has the power to turn into an adult superhero.

13 January 2018
Brookdale Senior Living Inc. - BKD - Stock Price Today
Traders may be trying to figure out whether it is a good time to enter or exit a position in Brookdale Senior Living Inc ( BKD ). Stifel Nicolaus maintained Brookdale Senior Living Inc . 563,561 are owned by Tiaa Cref Inv Ltd Liability Company. (NYSE: BKD ).

13 January 2018
Supreme Court hears arguments over Ohio's voter registration law
Government officials across the United States try to maintain accurate voter rolls by removing people who have died or moved away. The Supreme Court is diving into state efforts to pare their voting rolls by targeting people who haven't voted in a while.

13 January 2018
Investors Buy Ford Motor (F) on Weakness
Following the sale, the executive vice president now owns 150,484 shares of the company's stock, valued at $6,710,081.56. First Republic Investment Management Inc increased General Mtrs Co (GM) stake by 12.13% reported in 2017Q3 SEC filing.

13 January 2018
Intel warns Meltdown and Spectre patches could cause slowdowns
We are working quickly with these customers to understand, diagnose and address this reboot issue. However, it is believed that this threat will be contained with an operating system patch.

13 January 2018
First Citizens Bank & Trust Co. Increases Holdings in DTE Energy Co (DTE)
Following the completion of the sale, the chairman now owns 83,000 shares in the company, valued at approximately $9,373,190. ILLEGAL ACTIVITY WARNING: This report was published by TrueBlueTribune and is owned by of TrueBlueTribune.

13 January 2018
After sacking vlogger Logan Paul, Google to now screen premium YouTube videos
Paul announced earlier that he was stepping away from posting videos following the outcry over his "suicide forest" video. Paul later posted a video apologizing for his actions, and stated that he would take a break from social media.

13 January 2018
Comcast to increase Internet speeds for customers in Colorado
The Xfinity app will get an update for home automation, including suggestions for scenes to trigger multiple device actions. However, numerous devices were one-function oriented, such as a smart light or a smart thermostat.

13 January 2018
(INTC) Shares Bought by Intact Investment Management Inc
Following the sale, the insider now directly owns 265,298 shares of the company's stock, valued at approximately $11,734,130.54. The average Wall Street analyst rating for Intel Corporation is Strong Buy, according to the average of 25 analyst scores.



Recommended